
This episode discusses private equity's involvement in healthcare, featuring Atul Gupta, Assistant Professor of Healthcare Management at the Wharton School. Topics include Walgreens' acquisition by Sycamore Partners, the growth of private equity investments in healthcare, and concerns about transparency and patient care.
Atul Gupta explains that private equity investments in healthcare peaked in 2021 but have since declined due to unfavorable economic conditions. However, early 2024 numbers suggest a potential resurgence in investment activity.
Gupta highlights the mixed effects of private equity on healthcare, noting that while it can bring efficiency and technological support, it may also lead to negative outcomes like reduced staffing and increased costs for patients.
The conversation touches on state-level regulatory actions aimed at increasing transparency in private equity transactions, particularly in Pennsylvania and California.
Gupta emphasizes the importance of aligning private equity incentives with patient care and suggests that future developments in healthcare investment should be closely monitored.
Atul Gupta discusses private equity's impact on healthcare, focusing on investment trends, transparency issues, and implications for patient care.

Private equity can be a vehicle for great good.Walgreens Acquired: What Private Equity Means for Your Healthcare
The evidence is pretty mixed.Walgreens Acquired: What Private Equity Means for Your Healthcare
We should all watch this space very carefully.Walgreens Acquired: What Private Equity Means for Your Healthcare